PPBT
Purple Biotech Ltd.
NASDAQ · Healthcare · Biotechnology · IL
$1.75
−11.62%Year over year
Reported trailing growth
- Revenue
- —
- EBITDA
- —
- EBIT
- —
- EPS
- +72.3%
- Free cash flow
- +12.1%
- Operating cash flow
- +12.2%
Forward estimates
Based on analyst estimates
- Revenue
- —
- EBITDA
- —
- EPS
- —
Three-year CAGR
- Revenue
- —
- EBITDA
- —
- EBIT
- —
- Net income
- —
- EPS
- -24.4%
- Free cash flow
- +61.4%
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Jun 1, 2026